Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

Brahmer Julie; Reckamp Karen L.; Baas Paul; Crino Lucio; Eberhardt Wilfried E. E.; Poddubskaya Elena; Antonia Scott; Pluzanski Adam; Vokes Everett E.; Holgado Esther; Waterhouse David; Ready Neal; Gainor Justin; Aren Frontera Osvaldo; Havel Libor; Steins Martin; Garassino Marina C.; Aerts Joachim G.; Domine Manuel; Paz-Ares Luis; Reck Martin; Baudelet Christine; Harbison Christopher T.; Lestini Brian; Spigel David R.

首页> 外文期刊>The New England journal of medicine >Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

【24h】

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

机译：Nivolumab与高等鳞状细胞非小细胞肺癌中的多西紫杉醇

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

BACKGROUND

机译：背景

著录项

来源
《The New England journal of medicine》 |2015年第2期|共13页
作者
Brahmer Julie; Reckamp Karen L.; Baas Paul; Crino Lucio; Eberhardt Wilfried E. E.; Poddubskaya Elena; Antonia Scott; Pluzanski Adam; Vokes Everett E.; Holgado Esther; Waterhouse David; Ready Neal; Gainor Justin; Aren Frontera Osvaldo; Havel Libor; Steins Martin; Garassino Marina C.; Aerts Joachim G.; Domine Manuel; Paz-Ares Luis; Reck Martin; Baudelet Christine; Harbison Christopher T.; Lestini Brian; Spigel David R.;
展开▼
作者单位

Sidney Kimmel Comprehens Canc Ctr Johns Hopkins Baltimore MD 21287 USA;

City Hope Comprehens Canc Ctr Duarte CA USA;

Netherlands Canc Inst Amsterdam Netherlands;

Univ Hosp Perugia Perugia Italy;

Univ Duisburg Essen Univ Klinikum Essen West German Canc Ctr Dept Med Oncol Essen Germany;

NN Blokhin Russian Canc Res Ctr Moscow Russia;

Univ S Florida Coll Med H Lee Moffitt Canc Ctr &

Res Inst Tampa FL 33612 USA;

Inst Marii Sklodowskiej Curie Ctr Onkol Warsaw Poland;

Univ Chicago Med &

Biol Sci Chicago IL USA;

Hosp Madrid Norte Sanchinarro Madrid Spain;

Oncol Hematol Care Cincinnati OH USA;

Duke Univ Med Ctr Durham NC USA;

Massachusetts Gen Hosp Boston MA 02114 USA;

Ctr Int Estudios Clin Santiago Chile;

Nemocnice Bulovce Prague Czech Republic;

Univ Heidelberg Hosp Thoraxklin Heidelberg Germany;

Fdn IRCCS Ist Nazl Tumori Milan Italy;

Erasmus MC Canc Inst Rotterdam Netherlands;

Hosp Univ Fdn Jimenez Diaz Madrid Spain;

Hosp Univ Virgen Rocio Seville Spain;

LungenClin Grosshansdorf Grosshansdorf Germany;

Bristol Myers Squibb Co Princeton NJ USA;

Bristol Myers Squibb Co Princeton NJ USA;

Bristol Myers Squibb Co Princeton NJ USA;

Sarah Cannon Res Inst Nashville TN USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类 R23;
关键词

相似文献

外文文献
中文文献
专利

1. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer [J] . Brahmer Julie, Reckamp Karen L., Baas Paul, The New England journal of medicine . 2015,第2期

机译：Nivolumab与高等鳞状细胞非小细胞肺癌中的多西紫杉醇
2. Nivolumab versus docetaxel in previously treated advanced non-small-cell lung cancer (CheckMate 017 and CheckMate 057): 3-year update and outcomes in patients with liver metastases [J] . Vokes E. E., Ready N., Felip E., Annals of oncology: official journal of the European Society for Medical Oncology . 2018,第4期

机译：Nivolumab与先前治疗的晚期非小细胞肺癌（Checkmate 017和Checkmate 057）的Docetaxel）：肝转移患者的3年更新和结果
3. Nivolumab Versus Docetaxel in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer: Two-Year Outcomes From Two Randomized, Open-Label, Phase III Trials (CheckMate 017 and CheckMate 057) [J] . Horn Leora, Spigel David R., Vokes Everett E., Journal of Clinical Oncology . 2017,第35期

机译：Nivolumab对先前治疗的非小细胞肺癌患者的多西紫杉醇：两年随机，开放标签，第III期试验的两年成果（Checkmate 017和Checkmate 057）
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. Pharmacology Profiles of ALK and FLT3 Kinase Inhibitors against Non-Small-Cell Lung Cancer Cells and Acute Myeloid Leukemia Cells with Cancer Driver Mutations [D] . 森政道 2019

机译：ALK和FLT3激酶抑制剂对非小细胞肺癌细胞和急性髓系白血病细胞的癌症驱动突变的药理作用
6. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer [O] . Julie Brahmer, Karen L. Reckamp, Paul Baas, -1

机译：Nivolumab与多西他赛治疗晚期鳞状细胞非小细胞肺癌
7. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer [O] . Julie Brahmer, Karen L. Reckamp, Paul Baas, 2015

机译：Nivolumab与高等鳞状细胞非小细胞肺癌中的多西紫杉醇

Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer

摘要

著录项

相似文献

相关主题

期刊订阅